Table 2.
Sp Activity (μmole/min.mg) (-G-6-P) | Sp activity (μmole/min.mg) (7.2mM G-6-P) | Activity ratio (-G-6-P/+G-6-P) | |
---|---|---|---|
WT Gsy2 | 1.03±0.03 | 1.73±0.03 | 0.6±0.01 |
Gsy2-R580A/R581A/R583A1 | 0.55±0.02 | 0.51±0.03 | 1.09±0.02 |
Gsy2-R587A/R589A/R592A1 | 0.38±0.01 | 0.35±0.02 | 1.09±0.01 |
Gsy2(1-640) +49mer T668P1 | 0.1±0.01 | 1.9±0.02 | 0.05±0.01 |
Gsy2-R589A/R592A | 0.1±0.01 | 1.56±0.02 | 0.11±0.01 |
Gsy2-R581C/R592C | 0.033±0.001 | 0.04±0.001 | NA |
Gsy2-R581C/R592C +200mM BME | 0.58±0.01 | 2.1±0.02 | 0.27±0.02 |
Gsy2-R581A/R592A | 0.41±0.02 | 1.88±0.04 | 0.28±0.03 |
Gsy2(1-640)-R589A/R592A + 49mer T668 | 0.03±0.01 | 0.03±0.01 | NA |
Data are from reference 16.